India's COVID-19 fatality rate has reduced from 3.3% to 2.87% today; lowest in the world: Health Ministry
Dr Balram Bhargava, Director General, Indian Council of Medical Research (ICMR), said, "The testings have gone up in the last few months, and 1.1 lakh samples are being tested every day."
Trending Photos
New Delhi: The government on Tuesday (May 26) said that a total of 60,490 patients have so far recovered from coronavirus across the nation and cited improvement in recovery rate in comparison to the global data of fatality.
Addressing media persons, Lav Agarwal, Joint Secretary in Union Ministry of Health and Family Welfare, said, "India's recovery rate is steadily improving from 7.1% in March to 41.6% today. Our COVID-19 fatality rate is among the lowest in the world: It has reduced from 3.3% to 2.87% today."
"The global average for case fatality is presently around 6.4%. For India, the figure is as low as 2.87%, one of the lowest among countries which have reported high number of COVID-19 cases," said Lav Agarwal, adding "4.4 deaths per lakh population have been reported for the world, while India has reported about 0.3 deaths per lakh population, which is amongst the lowest in the world. This has been due to lockdown, timely identification, and management of coronavirus cases."
#CoronaVirusUpdates:
India has reported 10.7 cases per lakh population in comparison to 69.9 cases per lakh population of World;
One of the lowest in the world: @MoHFW_INDIA
#IndiaFightsCorona pic.twitter.com/hJZ0qSlTn4 — PIB India #StayHome #StaySafe (@PIB_India) May 26, 2020
Dr Balram Bhargava, Director General, Indian Council of Medical Research (ICMR), said, "The testings have gone up in the last few months, and 1.1 lakh samples are being tested every day."
"In terms of fatality rate, we have surprisingly found a low fatality rate in India, which is very good. There are several hypotheses on this, but we can't say anything clearly on any factor. Hope it continues," the ICMR DG said.
According to him, "Lot of drugs are being repurposed for COVID-19. Taking biological plausibility, in-vitro data, and safety of this drug (HCQ), we recommened it under strict medical supervision. Based on risk-benefit we found that possibly we should not deny our health workers from using it."
Giving an update on coronavirus situation, the ministry stated that the Centre along with the states/UTs is taking several steps for prevention, containment and management of COVID-19 through a graded, pre-emptive, and pro-active approach. These are being regularly reviewed and monitored at the highest level.
"The focus of the administration continues to be on prevention and containment measures so as to limit the spread of infection. Following required hand hygiene, respiratory hygiene and effective sanitation of frequently touched surfaces are critical to avoid getting the infection," it said.
It further said, "There is a need to ensure COVID appropriate behaviour to tide over this crisis. This also includes regular use of the masks/face covers and working towards protecting the elderly and vulnerable. Maintenance of physical distancing in public is the social vaccine the world currently has against the novel coronavirus."
The ministry said that India is now testing approximately 1.1 lakh samples per day, adding "Capacity has been increased by augmenting the number of labs, shifts, RT-PCR machines, and manpower."
"As of today, India has 612 total labs, 430 run by ICMR and 182 in the private sector to test the population for COVID-19 infection. Guidelines have been issued to states/UTs advising immediate testing for symptomatic and home quarantine for asymptomatic migrant workers," the ministry added.
Stay informed on all the latest news, real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.
Live Tv